| Product Name |
Fulvestrant EP Impurity C |
| Product Category | Impurities, Intermediates |
| Sub-Category | Metabolites, Sulphur and Selenium Compounds, Pharmaceutical Standards, Fine Chemicals, Steroids |
| CAS No | N/A |
| Catalog Number | GS.47.FUL.03 |
| Chemical Name/Synonyms | Fulvestrant Extended; 7ξ-[9-[[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol; 7-[9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol;(8R,9S,13S,14S,17S)-13-Methyl-7-(9-((9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; |
| Molecular Weight | 781.08 |
| Molecular Formula | C41H65F5O4S2 |
| Purity | NLT 95 % |
| Applications | It is an impurity of Fulvestrant which is used to treat hormone receptor-positive (HR+) and HER2-negative metastatic breast cancer in postmenopausal women |
| Inventory Status | customized |